MARLBOROUGH, Mass.,
April 1, 2016 /PRNewswire/
-- Boston Scientific Corporation (NYSE: BSX) will webcast its
conference call discussing financial results and business
highlights for the first quarter ended March
31, 2016 on Wednesday, April 27,
2016 at 8:00 a.m. ET.
The call will be hosted by Mike
Mahoney, president and chief executive officer, and
Dan Brennan, executive vice
president and chief financial officer.
A live webcast of the conference call will be available via the
Boston Scientific website. Webcast registration is available on the
Investor Relations section of the website at
www.bostonscientific.com/investors. Interested parties are
encouraged to register at least 15 minutes prior to the scheduled
start time to ensure a timely connection.
An archived replay of the webcast will be accessible at
www.bostonscientific.com/investors approximately one hour following
the completion of the conference call and available for
approximately one year.
The company will issue a news release announcing financial
results for the first quarter on Wednesday,
April 27, 2016, prior to the conference call.
About Boston Scientific
Boston Scientific transforms
lives through innovative medical solutions that improve the health
of patients around the world. As a global medical technology
leader for more than 35 years, we advance science for life by
providing a broad range of high performance solutions that address
unmet patient needs and reduce the cost of healthcare. For
more information, visit www.bostonscientific.com and connect on
Twitter and Facebook.
CONTACTS
|
Media:
|
Investors:
|
Tom
Keppeler
|
Susie Lisa,
CFA
|
508-683-6585
(office)
|
508- 683-5565
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
thomas.keppeler@bsci.com
|
investor_relations@bsci.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/boston-scientific-to-webcast-conference-call-discussing-first-quarter-2016-financial-results-on-april-27-300244236.html
SOURCE Boston Scientific Corporation